CAPS Rating

drneuro (55.58)

Results 1 - 20 of 43 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
24/10/2012 CPST.US 3 out of 5 Outperform 5Y $0.98 $1.17 (+1.74%) +19.50% +15.31% +4.19
16/05/2011 NBG.US 3 out of 5 Outperform 5Y $68.50 $5.16 (-2.46%) -92.47% +22.38% -114.85
17/06/2008 CZZ.US 3 out of 5 Outperform 3Y $10.87 $16.46 (-2.37%) +51.45% +23.80% +27.66
02/10/2006 17/06/2008 IMAX.US 4 out of 5 Outperform 5Y $4.91 $25.69 (+2.27%) +423.22% +29.94% +393.28
25/04/2008 HNP.US 2 out of 5 Outperform 3Y $26.88 $36.45 (-1.59%) +35.58% +21.59% +13.99
24/04/2008 JMBA.US 3 out of 5 Outperform 1Y $12.40 $16.09 (-1.35%) +29.76% +23.68% +6.08
28/03/2008 CRNT.US 4 out of 5 Outperform 5Y $9.78 $3.50 (-2.51%) -64.21% +27.90% -92.11
18/03/2008 MTENY.US 5 out of 5 Outperform 5Y $4.81 $0.63 (+0.32%) -86.91% +29.24% -116.14
18/03/2008 TLK.US 5 out of 5 Outperform 5Y $33.22 $42.68 (-1.61%) +28.50% +29.20% -0.70
18/03/2008 MYTAY.US 4 out of 5 Outperform 5Y $13.93 $7.62 (-1.93%) -45.28% +29.20% -74.48
17/03/2008 PETS.US 5 out of 5 Outperform 5Y $9.21 $13.33 (-0.45%) +44.71% +34.58% +10.13
11/02/2008 PDFS.US 5 out of 5 Outperform 1Y $5.96 $18.44 (-0.43%) +209.40% +27.98% +181.42
30/01/2008 MWA.US 4 out of 5 Outperform 5Y $7.70 $6.51 (-3.27%) -15.50% +25.64% -41.14
29/01/2008 GEX.US 1 out of 5 Outperform 5Y $43.24 $15.29 (-1.74%) -64.64% +25.16% -89.80
29/01/2008 GMK.US 5 out of 5 Outperform 5Y $11.12 $17.34 (-2.14%) +55.94% +25.16% +30.77
29/01/2008 TCM.US 2 out of 5 Outperform 5Y $8.42 $4.44 (0%) -47.27% +25.16% -72.43
29/01/2008 SBS.US 5 out of 5 Outperform 5Y $5.87 $11.11 (-5.29%) +89.38% +25.16% +64.22
29/01/2008 EXEL.US 5 out of 5 Outperform 5Y $7.36 $4.72 (-2.07%) -35.87% +25.16% -61.03
29/01/2008 BWLD.US 4 out of 5 Outperform 5Y $23.15 $99.17 (-0.13%) +328.38% +25.16% +303.22
29/01/2008 IMMR.US 3 out of 5 Outperform 3Y $9.04 $14.31 (-2.79%) +58.30% +25.16% +33.14
Results 1 - 20 of 43 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.